- Home
- DARE vs ZCMD Comparison
DARE vs ZCMD Comparison
Compare DARE & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- ZCMD
- Stock Information
- Founded
- DARE 2015
- ZCMD 2012
- Country
- DARE United States
- ZCMD China
- Employees
- DARE N/A
- ZCMD N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- ZCMD Other Consumer Services
- Sector
- DARE Health Care
- ZCMD Real Estate
- Exchange
- DARE Nasdaq
- ZCMD Nasdaq
- Market Cap
- DARE 26.3M
- ZCMD 28.5M
- IPO Year
- DARE N/A
- ZCMD 2020
- Fundamental
- Price
- DARE $2.50
- ZCMD $1.10
- Analyst Decision
- DARE Strong Buy
- ZCMD
- Analyst Count
- DARE 3
- ZCMD 0
- Target Price
- DARE $12.50
- ZCMD N/A
- AVG Volume (30 Days)
- DARE 4.4M
- ZCMD 241.3K
- Earning Date
- DARE 08-11-2025
- ZCMD 01-01-0001
- Dividend Yield
- DARE N/A
- ZCMD N/A
- EPS Growth
- DARE N/A
- ZCMD N/A
- EPS
- DARE N/A
- ZCMD N/A
- Revenue
- DARE $25,909.00
- ZCMD $15,864,773.00
- Revenue This Year
- DARE $74,787.57
- ZCMD N/A
- Revenue Next Year
- DARE $141.76
- ZCMD N/A
- P/E Ratio
- DARE N/A
- ZCMD N/A
- Revenue Growth
- DARE N/A
- ZCMD N/A
- 52 Week Low
- DARE $2.11
- ZCMD $0.95
- 52 Week High
- DARE $9.19
- ZCMD $2.97
- Technical
- Relative Strength Index (RSI)
- DARE 44.37
- ZCMD 47.03
- Support Level
- DARE $2.11
- ZCMD $1.10
- Resistance Level
- DARE $9.19
- ZCMD $1.24
- Average True Range (ATR)
- DARE 0.62
- ZCMD 0.08
- MACD
- DARE 0.03
- ZCMD -0.01
- Stochastic Oscillator
- DARE 5.51
- ZCMD 14.93
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.